ClinicalTrials.gg
RecruitingNCT06663384ARVISUpdated Sep 9, 2026

ARVIS TKA vs Conventional TKA

An interventional study of Evaluation of Augmented Reality technology in TKA compared to standard TKA in Osteoarthritis, sponsored by Foundation for Orthopaedic Research and Education. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Foundation for Orthopaedic Research and Education · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,029 studies in Osteoarthritis with a site in United States — 116 open to participants now, 175 under way, 14 of them phase 3. Osteoarthritis · United States.

Planned enrollment
579th of 832
50 · median 100
Started
2024
with 16 others
No phase
437 of 1,029
54 open now
Primary completion
2026-11
later than 52 of 174 live
Registered
959th of 1,029
by date

Among the 1,029 studies in Osteoarthritis with a site in United States, this one is the 579th largest by planned enrollment of the 832 interventional ones that give a count, is one of 17 that started in 2024, is one of 437 with no phase, reaches primary completion later than 52 of the 174 other live ones, and was the 959th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

116 of the 1,029 studies in Osteoarthritis with a site in United States are open now. Recruiting first, the newest first:

111 more — sign in →

All 116 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,029 studies in Osteoarthritis with a site in United States, or all of them as a file.
02

Study summary

This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

Read the detailed description

This study is a Randomized Controlled Trial evaluating the effectiveness of an AR system utilized to perform bone cuts when compared to traditional jigs in primary TKA for treatment of primary osteoarthritis. Our primary objective is to determine if the ARVIS augmented reality platform is a reliable tool to restore native lower extremity alignment during TKA. An estimated 50 patients will be enrolled in the study, with 25 in the AR-group and 25 in the non-AR conventional kinematic alignment group. A 20% attrition rate (10 patients) is expected throughout the study, leaving 20 patients in each study group. The Investigator intend to evaluate only patients who've met the clinical and radiographic indications for TKA for one knee (Killgren Lawrence Grade > III) and have less than Killgren Lawrence Grade II OA of the contralateral knee. The Investigators intend to use the uninvolved knee as a radiographic comparison to determine ARVIS's post-operative restorative accuracy to the patient's native alignment. Pre- and post-operative radiographs will include standing knee AP, PA, lateral, sunrise, and hip-to-ankle radiographs.

The investigators have chosen to reproduce the patient's native alignment during TKA rather than mechanical alignment given the predominance of recent literature demonstrating superior function and outcome of kinematic based techniques. Intraoperatively, the investigators will use ARVIS to prospectively record bone resection thickness, distal femoral resection angle, femoral component sagittal orientation, femoral component rotation, tibial resection thickness, coronal tibial resection angle, and tibial slope.

The ARVIS is an augmented reality headset with a heads-up display capable of presenting pre-resection hip center and lower extremity alignment. The heads-up display provides real time, intra-operative feedback during bone resections to optimize the component position and lower extremity alignment as compared to the uninvolved contralateral limb. Unlike other methods used to prepare bone cuts during TKA, such as traditional jigs or robotic systems, ARVIS is a self-contained, wearable surgical guidance device controlled by the surgeon, designed to ensure surgeon can focus on their patient while they perform bone cuts on tibia and femur - not a screen across the room.

The procedure of TKA is the same for traditional approach utilizing jigs and ARVIS approach.

ARVIS has received 510(k) clearance from the FDA as of July 2021.

03

Conditions studied

  • Osteoarthritis

Keywords

  • osteoarthritis of knee, Total Knee Replacement
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18 years old
  • Scheduled for primary conventional TKA with kinematic alignment
  • Primary Diagnosis of Osteoarthritis (Killgren Lawrence Grade > III) on affected side
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  1. Patients with a previous operation of the same knee, including ACL reconstruction, fracture fixation, previous arthroplasty.
  2. Patients that had a conversion to a different procedure intraoperatively or shortly after the TKA.
  3. Diagnosed with greater than Killgren Lawrence Grade II OA on the contralateral knee
  4. Patients that did not complete the TKA.
  5. Patients the Investigator deems not able to follow through with study requirements such as follow-up visits or PROM's.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    ARVIS arm

    TKA using ARVIS software

    Other: Evaluation of Augmented Reality technology in TKA compared to standard TKA

  • Placebo comparator
    conventional TKA

    Conventional Total Knee Arthroplasty

    Other: Evaluation of Augmented Reality technology in TKA compared to standard TKA

Interventions

  • OtherEvaluation of Augmented Reality technology in TKA compared to standard TKA

    Evaluation of effectiveness of AR system used to perform bone cuts when compared to traditional jigs in primary TKA

06

What researchers measure

Primary outcomes

  1. Radiographic Measurements bilateral knees

    Weight bearing anterposterior (AP), lateral and sunrise views of both knees to measure tibial slope, hip-knee alignment, medial proximal tibial angle, mechanical lateral distal femoral angle, joint line convergence angle, anatomic- mechanical angle.

    Time frame: From enrollment until 1 year follow-up visit.

Secondary outcomes

  1. PROMIS-10 Survey

    Patient Reported Outcome Measure Information System with 10 questions about subjects pain and function.

    Time frame: frome enrollment until 12 month final study visit

  2. Knee Society Score (KSS)

    A simple and objective scoring system to rate the knee and patient's functional abilities before and after total knee arthroplasty.

    Time frame: From enrollment until final visit at 12 months after surgery

  3. Knee Injury and Osteoarthritis outcome Score (KOOS)

    KOOS is a 42-item questionnaire that assesses the patient's opinion about the health, symptoms, and functionality of their knee.

    Time frame: from enrollment until completion of study at 12 months post surgery

  4. Numeric Pain Rating Score (NPRS)

    1-10 numeric scale that asks patients to rate their pain in the last 24 hours.

    Time frame: From enrollment until final study visit at 12 months post surgery

Other outcomes

  1. Virtual Reality Sickness Questionnaire (VSRQ)

    A motion sickness measurement index specialized in VR environments. 16 questions broken down into three categories (nausea, oculomotor, and disorientation) to assess the severity of each potential cybersickness symptom.

    Time frame: After the surgical procedure - one time only

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — This is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Nov 2026, 23 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 23 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2024
First posted
Oct 29, 2024
StartActual
Dec 1, 2024
Primary completionEst.
Nov 1, 2026
CompletionEst.
Nov 1, 2027
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06663384
Lead sponsor
Foundation for Orthopaedic Research and Education
Collaborators
DonJoy Orthopedics
Responsible party
Sponsor
First posted
Oct 29, 2024
Start date
Dec 1, 2024
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Debbi Warren, RN
Contact
dwarren@foreonline.org
813-910-3688
Peter Simon
Contact
psimon@foreonline.org
312-509-5761
Brian Palumbo, MD
principal investigator · Florida Orthopaedic Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion